Dr Reddy’s Laboratories is also working on a generic version of Wegovy. (Image/Getty) US pharma major Eli Lilly on Thursday launched its global bestseller anti-obesity and diabetes drug Mounjaro ...

US pharma major Eli Lilly on Thursday launched the much-awaited diabetes and obesity management drug Mounjaro in India at one-fifth of US price. Lilly launched the drug in a single dose vial following ...

American pharmaceutical major Eli Lilly and Company on Thursday (March 20, 2025) launched its diabetes and obesity management drug Mounjaro (tirzepatide) in India. The company launched the drug in ...

With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight ...

India has taken a major step in the fight against obesity and diabetes with the launch of Mounjaro, a groundbreaking drug from American pharmaceutical giant Eli Lilly and Co. The company announced ...

Approved by the Central Drugs Standard Control Organization (CDSCO), Mounjaro® is available in single-dose vials, with pricing set at Rs3,500 for a 2.5 mg vial and Rs4,375 for a 5 mg vial ...

New Delhi: Eli Lilly has officially introduced Mounjaro (tirzepatide) in India, marking a major milestone in diabetes and weight-loss treatment. The drug, which has seen tremendous global demand ...

(Reuters) -Eli Lilly has launched its blockbuster diabetes and weight-loss drug Mounjaro in India following approval from the country’s drug regulator, it said on Thursday. Global demand for Lilly’s ...

Eli Sharabi, who survived Hamas captivity and whose family was murdered during the October 7th Massacre, arrived at the United Nations in New York where he will brief the ambassadors of the ...

Obesity is linked to more than 200 health complications, including hypertension The 2.5 mg vial is priced at 3,500 rupees ($40.5) and the 5 mg vial is priced at 4,375 rupees. Bloomberg Follow ...

New Delhi [India], March 20 (ANI): Global pharmaceutical company Eli Lilly and Company (India) has introduced Mounjaro (tirzepatide) in India, a breakthrough drug for the treatment of Type 2 ...

Investing.com -- U.S. pharmaceutical company Eli Lilly (NYSE:LLY) has introduced its diabetes and weight-loss drug Mounjaro in India, ahead of its competitor Novo Nordisk (NYSE:NVO). This comes as ...